Back to Search
WAJEH QUNIBI, M.D.
M.D.
Nephrology Physician
NPI: 1831109636IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
F0629(TX)
Education
OTHER
Class of 1971
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
PMID 40576086·Cochrane Database Syst Rev·2025
1-meta
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
PMID 18423809·Am J Kidney Dis·2008
4-observational
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
PMID 12081584·Kidney Int·2002
3-trial
Reducing the burden of cardiovascular calcification in patients with chronic kidney disease.
PMID 16251249·J Am Soc Nephrol·2005
6-review
Does sevelamer have anti-atherosclerotic properties in maintenance hemodialysis patients?
PMID 16932359·Nat Clin Pract Nephrol·2005
8-other
Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes.
PMID 15954917·Kidney Int·2005
8-other
Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end-stage renal disease (ESRD).
PMID 15882313·Kidney Int Suppl·2005
6-review
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study.
PMID 15296505·Kidney Int Suppl·2004
6-review
Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD).
PMID 15296501·Kidney Int Suppl·2004
6-review
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).
PMID 15086935·Kidney Int·2004
3-trial
Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.
PMID 12410860·Kidney Int Suppl·2002
6-review
Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
PMID 18971017·Am J Kidney Dis·2008
8-other
The CARE-2 study results: setting the record straight.
PMID 18820282·Nephrol Dial Transplant·2008
8-other
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
PMID 18078907·Acad Radiol·2008
4-observational
Effects of sevelamer and calcium on coronary artery calcification in patients new to dialysis: time for better controlled clinical trials.
PMID 16528261·Kidney Int·2006
8-other
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
PMID 15882308·Kidney Int Suppl·2005
6-review
Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis.
PMID 15824508·Nephron Clin Pract·2005
3-trial
Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications.
PMID 15296506·Kidney Int Suppl·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7703 FLOYD CURL DR, MC 7977
SAN ANTONIO, TX 78229 - Phone
- (210) 257-1400
Quick Facts
- NPI
- 1831109636
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 55
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile